secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K
Filed at:   2022-08-05T23:59:59+00:00
Accession:  0001437749-22-019059
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo Q2 2022 revenue ~$1.3M, up 185% YoY; preliminary figures
-----------------------------------------------------------------

- Q2 revenue ~$1.3M, up 37% sequentially and 185% vs Q2 2021.
- Growth driven by POOPH retail launch, PFAS treatment tech, waste-to-energy project.
- National nuclear fuel innovator prototype project expected to expand after successful Phase 1.
- Full Q2 results due in Form 10-Q by Aug 15, 2022; figures preliminary and unaudited.
- Company plans investor webcast shortly after 10-Q filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774922019059/0001437749-22-019059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774922019059/blgo20220804_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-019059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer